beta

CBM

Cambrex Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.

Market Cap: 2.02 Billion

Primary Exchange: New York Stock Exchange

Website: http://www.cambrex.com

Shares Outstanding: 33.7 Million

Float: 33.4 Million

Dividend: (%)

Beta: 0.827768372640017

Sector: Process Industries

Industry: Chemicals: Specialty

Ethical Flags

Longest drawdown: 679 trading days

From: 2018-09-28 To: 2019-12-03

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud